SCHEMBL24921982

SCHEMBL24921982

COc1ncc(-c2noc(C)n2)nn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
HSD17B10 Q99714 3/20 0.40
KDM4E B2RXH2 3/20 0.40
GAA P10253 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RAB9A P51151 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
NPC1 O15118 2/20 0.39
TSHR P16473 2/20 0.39
LMNA P02545 2/20 0.38
ATM Q13315 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
CHEK1 O14757 1/20 0.34
EGFR P00533 1/20 0.34
NTRK1 P04629 1/20 0.34
RET P07949 1/20 0.34
ROS1 P08922 1/20 0.34
KIT P10721 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24921484 0.78 L3MBTL1 (0.49) MAPTHSD17B10KDM4EGAANPSR1
SCHEMBL24921515 0.75 HSD17B10 (0.40) MAPTHSD17B10KDM4EGAANPSR1
SCHEMBL24920805 0.74 KDM4E (0.43) MAPTHSD17B10KDM4EGAANPSR1
SCHEMBL24922000 0.74 CNR2 (0.38) MAPTHSD17B10RAB9AHPGDNPC1
SCHEMBL24921985 0.73 CNR2 (0.33)
SCHEMBL24921482 0.73 MAPT (0.48) MAPTHSD17B10KDM4EGAANPSR1
SCHEMBL24921562 0.72 RAB9A (0.56) MAPTHSD17B10KDM4EGAANPSR1
SCHEMBL12267166 0.70 L3MBTL1 (0.43) MAPTHSD17B10KDM4EGAANPSR1
SCHEMBL24921462 0.70 L3MBTL1 (0.40) MAPTHSD17B10KDM4EGAANPSR1
SCHEMBL24921979 0.70 PTGDR (0.39) RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed